Adzenys ER
- Product NDC
- 70165-003
- 11-digit product format
- 701650003
- Labeler code
- 70165
- Product ID
- 70165-003_c3cb469d-d045-c37f-e053-2a95a90a34cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amphetamine
- Dosage form
- SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Neos Therapeutics Brands, LLC
- Application
- NDA204325
- Marketing category
- NDA
- Marketing start
- 2017-09-16
- Marketing end
- 0000-00-00
- Substance
- AMPHETAMINE
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 70165-003 | D | Discontinued by firm | 2026-08-07 | ||
| excluded package | package | 70165-003 | 70165-003-15 | D | Discontinued by firm | 2026-08-07 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 70165-003-15 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 70165-003-15 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 70165-003-15 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 70165-003-15 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 70165-003-15 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 70165-003-15 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70165-003-15 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70165-003-15 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70165-003-15 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 70165-003-15 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 70165-003-15 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 70165-003-15 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 70165-003-15 | E | Excluded after deficient or non-compliant submission was not corrected | 110d247fa046… | a55b01930146… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204325-001 | ADZENYS ER | AMPHETAMINE | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | |
| N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | |
| N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2017-09-15 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2017-09-15 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2017-09-15 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2017-09-15 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2017-09-15 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2017-09-15 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2017-09-15 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2017-09-15 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N204325-001 | ADZENYS ER | EQ 1.25MG BASE/ML | SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2017-09-15 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204325-001 | 9017731 | 2032-06-28 | Drug product | 2017-09-21 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N204325-001 | 9265737 | 2032-06-28 | Drug product | 2017-09-21 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N204325-001 | 8709491 | 2032-06-28 | Drug product | 2017-09-21 | 8072bd15b7f6… |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70165-003-15 | ML - Milliliter | 70165-003 | b8a3461b-0992-4c70-abbe-f13bbad95044 | 1 | 2018-02-20 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70165-003-15 | 70165000315 | 450 mL in 1 BOTTLE, GLASS (70165-003-15) | 450 ml | 2017-09-16 | 0000-00-00 | No | No | Current |